中原建業(09982.HK)獲主席胡葆森增持450萬股
格隆匯9月27日丨中原建業(09982.HK)公吿,董事會獲控股股東恩輝投資有限公司("恩輝",其由公司主席、非執行董事兼控股股東胡葆森全資擁有)吿知,於2021年9月10日至2021年9月24日期間,恩輝於公開市場以平均價格每股1.43港元購買450萬股公司股份,總額為6,451,440港元(不包括相關交易費)。
董事會認為,胡增持股權充分表明彼對公司整體發展前景及增長潛力的長期承諾及信心。緊隨收購後,胡於2,063,631,867股股份(相當於公司於公吿日期已發行股本總額約62.62%)中擁有權益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.